However, our primary hypothesis that the serum TRX-1 levels would be a predictor for the development of severe BPD and severe ROP was not supported; there was no statistically significant relationship between serum TRX-1 levels at any point and the development of severe BPD and ROP in EPIs. The gene discussed is TXN; the disease is bronchopulmonary dysplasia.